Publication: An overview of emerging immunotargets of genitourinary tumors
An overview of emerging immunotargets of genitourinary tumors
Date
Date
Date
Citations
Montironi, R., Santoni, M., Cheng, L., Lopez-Beltran, A., Massari, F., Matrana, M. R., Moch, H., & Scarpelli, M. (2015). An overview of emerging immunotargets of genitourinary tumors. Current Drug Targets, 17, 1. https://doi.org/10.2174/1389450117666151209144649
Abstract
Abstract
Abstract
Emerging immunotherapies targeting immune checkpoints and tumor associated antigens are leading to important clinical advances and providing a new weapon in patients with prostate (PCa) and bladder cancer (BC) and, in particular, with renal cell carcinoma (RCC). The possibility to integrate these agents in the current therapeutic scenario or genitourinary tumors, both in sequential or combined approaches, relies on a more profound comprehension of the pro-tumorigenic activity of the immune system and of the mechanisms of cancer-relate
Metrics
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Page Range
Page Range
Page Range
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Views
Citations
Montironi, R., Santoni, M., Cheng, L., Lopez-Beltran, A., Massari, F., Matrana, M. R., Moch, H., & Scarpelli, M. (2015). An overview of emerging immunotargets of genitourinary tumors. Current Drug Targets, 17, 1. https://doi.org/10.2174/1389450117666151209144649